Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00522782 · ClinicalTrials.gov registry record · Phase 4
Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
A Phase 4 study, sponsored by AAADRS Clinical Research Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT00522782: Completed Phase 4 study, sponsored by AAADRS Clinical Research Center.
NCT00522782 is a Phase 4 study that has completed, run by AAADRS Clinical Research Center. The registered enrollment target is 16 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00522782, a Phase 4 study, has completed, sponsored by AAADRS Clinical Research Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
To study the improvement in airway inflammation in children with asthma non-invasively with exhaled breath NO, a marker of inflammation, after therapy with nebulized budesonide as 0.5mg daily.
Interventions
- DRUG Nebulized Budesonide
- DEVICE Nitric Oxide Analyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-01 |
| Phase | Phase 4 |
What the finished NCT00522782 record still lists
NCT00522782 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Nebulized Budesonide is the first listed.
NCT00522782 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00522782 about?
NCT00522782 is a clinical study titled "Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children". To study the improvement in airway inflammation in children with asthma non-invasively with exhaled breath NO, a marker of inflammation, after therapy with nebulized budesonide as 0.5mg daily.
What is the current status of trial NCT00522782?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2007-08. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00522782?
The interventions under investigation include: Nebulized Budesonide (DRUG), Nitric Oxide Analyzer (DEVICE).
Who is sponsoring clinical trial NCT00522782?
This trial is sponsored by AAADRS Clinical Research Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00522782's enrollment target sits among peer trials
16 1869th of 2000 higher than 121 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia